ZENKE; Gerhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZENKE; Gerhard.The latest application filed is for "2,4- diaminopyrimidine derivatives".

Company Profile

0.13.17

ZENKE; Gerhard - Rheinfelden DE
Zenke; Gerhard - Basel CH
Zenke; Gerhard - Rheinfelden 79618 DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,4- Diaminopyrimidine Derivatives App 20130345180 - BAENTELI; Rolf ; et al.	2013-12-26
2,4-diaminopyrimidine derivatives Grant 8,431,589 - Baenteli , et al. April 30, 2	2013-04-30
2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors Grant 8,283,356 - Baenteli , et al. October 9, 2	2012-10-09
2,4- Diaminopyrimidine Derivatives App 20110172231 - BAENTELI; Rolf ; et al.	2011-07-14
2,4-diaminopyrimidine derivatives Grant 7,943,627 - Baenteli , et al. May 17, 2	2011-05-17
Indolylmaleimide derivatives Grant 7,825,124 - Albert , et al. November 2, 2	2010-11-02
Indolylmaleimide derivatives Grant 7,786,123 - Albert , et al. August 31, 2	2010-08-31
2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors App 20100152182 - Baenteli; Rolf ; et al.	2010-06-17
2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors Grant 7,671,063 - Baenteli , et al. March 2, 2	2010-03-02
Indolylmaleimide Derivatives App 20090318463 - Albert; Rainer ; et al.	2009-12-24
Indolylmaleimide derivatives Grant 7,534,808 - Evenou , et al. May 19, 2	2009-05-19
Indolylmaleimide Derivatives App 20080146578 - Evenou; Jean-Pierre ; et al.	2008-06-19
Indolylmaleimide derivatives App 20080108628 - Evenou; Jean-Pierre ; et al.	2008-05-08
Indolylmaleimide derivatives Grant 7,358,253 - Evenou , et al. April 15, 2	2008-04-15
Indolylmaleimide derivatives App 20070191401 - Albert; Rainer ; et al.	2007-08-16
Indolylmaleimide derivatives App 20070184061 - Albert; Rainer ; et al.	2007-08-09
Indolylmaleimide derivatives App 20070155817 - Albert; Rainer ; et al.	2007-07-05
Indolylmaleimide derivatives Grant 7,235,555 - Evenou , et al. June 26, 2	2007-06-26
Indolylmaleimide derivatives Grant 7,220,774 - Albert , et al. May 22, 2	2007-05-22
Indolylmaleimide derivatives App 20070037826 - Evenou; Jean-Pierre ; et al.	2007-02-15
Indolylmaleimide derivatives App 20070032507 - Evenou; Jean-Pierre ; et al.	2007-02-08
2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors App 20060247262 - Baenteli; Rolf ; et al.	2006-11-02
Pyrimidine derivaties App 20060100227 - Baenteli; Rolf ; et al.	2006-05-11
Indolylmaleimide derivatives App 20050119274 - Evenou, Jean-Pierre ; et al.	2005-06-02
Indolylmaleimide derivatives App 20040053949 - Albert, Rainer ; et al.	2004-03-18
Indolylmaleimide derivatives Grant 6,645,970 - Albert , et al. November 11, 2	2003-11-11
Indolylmaleimide derivatives App 20030069424 - Albert, Rainer ; et al.	2003-04-10
Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin Grant 6,455,518 - Zenke , et al. September 24, 2	2002-09-24
Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin App 20010008888 - Zenke, Gerhard ; et al.	2001-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.